clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
artificial intelligence
DNAnexus Wins Five-Year, $20M Contract to Power precisionFDA Platform
News & Features
Veracyte Nabs Exclusive Global License for Diagnostic Use of Nanostring’s nCounter…
Bioinformatics
Mayo Clinic Names Head of New Digital Healthcare Platform
News & Features
Duke Researchers Show How Stem Cell Mutations Arise and Metastasize in…
News & Features
Blood Test that Measures Expression of 5,000 Proteins Shows Potential as…
Topics
All
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
artificial intelligence
DNAnexus Wins Five-Year, $20M Contract to Power precisionFDA Platform
News & Features
Veracyte Nabs Exclusive Global License for Diagnostic Use of Nanostring’s nCounter…
Bioinformatics
Mayo Clinic Names Head of New Digital Healthcare Platform
News & Features
Duke Researchers Show How Stem Cell Mutations Arise and Metastasize in…
Magazine
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 2
Multimedia
All
Webinars
eBooks
Webinars
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Multimedia
Single-Cell Functional Proteomics Accelerates Immunotherapy Development Opportunities from Pre-Clinical to Clinical…
Webinars
The Next Era in Pathway Proteomics: Turnkey Targeted Quantitation Workflows
Webinars
Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Authors
Posts by Chris Anderson
Chris Anderson
138 POSTS
0 COMMENTS
Editor in Chief
News & Features
Veracyte Nabs Exclusive Global License for Diagnostic Use of Nanostring’s nCounter...
December 6, 2019
News & Features
Duke Researchers Show How Stem Cell Mutations Arise and Metastasize in...
December 4, 2019
News & Features
Teamsters Health and Welfare Fund of Philadelphia Taps Color for Genomic...
December 3, 2019
Diabetes
Digbi Health’s Obesity, Diabetes Digital Therapeutics Program Offered by Blue Shield...
November 29, 2019
News & Features
The Broad’s Genotype/Phenotype Diagnostic Approach Helps Unravel Antimicrobial Resistance
November 27, 2019
News & Features
Changing Methodology Helps Discover New Alzheimer’s Risk Gene
November 25, 2019
News & Features
Study Follows Pattern of Glioma Tumor Evolution
November 25, 2019
News & Features
One-in-Three Cancer Patients Didn’t Receive Enough Information on Treatment Side Effects
November 25, 2019
News & Features
DiamiR Nabs Grant to Develop Alzheimer’s Disease Diagnostic
November 22, 2019
News & Features
Mount Sinai Team Finds New Molecular Drivers of Parkinson’s
November 20, 2019
1
2
3
...
14
Page 1 of 14
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. [Visual Mozart/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1628-324x160.jpeg "Digbi Health’s Obesity, Diabetes Digital Therapeutics Program Offered by Blue Shield of California")
![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-324x160.jpeg "DiamiR Nabs Grant to Develop Alzheimer’s Disease Diagnostic")
